Announcement on Completion of Election of New Board of Directors and Appointment of Senior Executives and Securities Affairs Representative
The abstract is for reference only. Please refer to the full text of the announcement on the very day.
(688293)"SHANGHAI OPM BIOSCIENCES CO., LTD."Announcement on Completion of Election of New Board of Directors and Appointment of Senior Executives and Securities Affairs Representative
Filed with SSE · Stock code 688293 · · 16 pages · Chinese
Summary by 6ix AI
Shanghai OPM Biosciences Co., Ltd. has announced the completion of its board of directors' election and the appointment of senior executives and a securities affairs representative. The new board consists of five non-independent directors and three independent directors, with the term lasting three years from the date of approval. Additionally, the company has appointed its general manager, deputy general managers, and a financial director during the first meeting of the new board. The announcement also notes the departure of some independent directors following the election.
Written in English by 6ix AI from the company’s Chinese-language filing. How 6ix writes summaries
Release
Shanghai OPM Biosciences Co., Ltd. on 6ix
Story so far
- Announcement on Adjustment of the Total Cash Dividend Amount for the 2026 Interim Profit Distribution
- Announcement on Results of the First Vesting for the Third Vesting Period of the Initial Grant and the Second Vesting Period of the Reserved Grant under the 2023 Restricted Share Incentive Plan and Listing of Shares
- Announcement on Listing and Trading of Restricted Shares from Private Placement of Shares in Connection with the Share Issuance and Cash Payment for Asset Acquisition and Raising of Supporting Funds
Earlier from Shanghai OPM Biosciences
- Announcement on Adjustment of the Total Cash Dividend Amount for the 2026 Interim Profit Distribution
- Announcement on Results of the First Vesting for the Third Vesting Period of the Initial Grant and the Second Vesting Period of the Reserved Grant under the 2023 Restricted Share Incentive Plan and Listing of Shares
- (688293)"SHANGHAI OPM BIOSCIENCES CO., LTD."Review Opinion and Statement on the Public Disclosure of the List of Participants for the Reserved Grant (First Batch) under the Company's 2026 Restricted Share and Share Appreciation Rights Incentive Plan Issued by the Remuneration and Appraisal Committee of the Board of Directors
- Announcement on Listing and Trading of Restricted Shares from Private Placement of Shares in Connection with the Share Issuance and Cash Payment for Asset Acquisition and Raising of Supporting Funds
- Announcement on Grant of Reserved Restricted Shares (First Batch) to Participants under the 2026 Restricted Share and Stock Appreciation Rights Incentive Plan
Later from Shanghai OPM Biosciences
All Shanghai OPM Biosciences news releasesFollow Shanghai OPM Biosciences into a list and get an email when it puts out news.
Follow Shanghai OPM Biosciences